ArticlePharmaceutics2025

Targeting Neuronal Nitric Oxide Synthase (nNOS) as a Novel Approach to Enhancing the Anti-Melanoma Activity of Immune Checkpoint Inhibitors.

Anika Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.